Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3752414013 | Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3752415014 | Phospholipid (as beractant) 25 mg/mL suspension for endotracheopulmonary instillation | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Is a | Product containing only beractant in pulmonary dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has basis of strength substance | Phospholipid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has concentration strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has precise active ingredient | Beractant | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has manufactured dose form | Conventional release suspension for endotracheopulmonary instillation | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR